» Articles » PMID: 11471092

Associations of Cardiovascular Disease and Its Risk Factors with Age-related Macular Degeneration: the POLA Study

Overview
Publisher Informa Healthcare
Date 2001 Jul 27
PMID 11471092
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

The POLA study (June 1995 through July 1997) is a population-based study on cataract and age-related macular degeneration (AMD) and their risk factors in 2584 residents of Séte (South of France), aged 60--95 years. Classification of AMD was performed on 50 degrees fundus photographs, according to an international classification. The presence of cardiovascular disease and its risk factors was determined by interviewer-based questionnaire, clinical examination (anthropometry, blood pressure) and fasting plasma measurements. Using a logistic model adjusted for age and gender, late AMD was not significantly associated with a history of cardiovascular disease, diabetes, use of hypocholesterolemic drugs, hypertension, blood pressure or plasma lipids. Obese subjects (body mass index greater than 30 kg/m( 2)) had a 2.29-fold (95% confidence interval (CI): 1.00--5.23) and 1.54-fold (CI: 1.05--2.26) increased risk of late AMD and pigmentary abnormalities in comparison with lean subjects. Finally, the risk of soft drusen was decreased in those subjects with a history of cardiovascular disease (odds-ratio (OR) = 0.72, CI: 0.54--0.97), and increased with increasing levels of HDL-cholesterol (OR = 1.52, CI: 1.14--2.02). None of these results were modified by further adjustments for smoking, educational level and plasma alpha-tocopherol. These results need to be confirmed by other studies, which ideally should be longitudinal and prospective.

Citing Articles

Interplay of Retinal and Choroidal Vasculatures in Ocular Health and Disease.

Gonzales A, Paikai A, Maeng D Adv Exp Med Biol. 2025; 1468:459-463.

PMID: 39930238 DOI: 10.1007/978-3-031-76550-6_75.


The association between age-related macular degeneration and risk of Parkinson disease: A systematic review and meta-analysis.

Meng M, Shen X, Xie Y, Wang J, Liu J Medicine (Baltimore). 2024; 103(46):e40524.

PMID: 39560583 PMC: 11576027. DOI: 10.1097/MD.0000000000040524.


Metabolic activity of visceral adipose tissue is associated with age-related macular degeneration: a pilot F-FDG PET/CT study.

Choi K, Joung C, Pahk K, Kim H, Pahk K Front Endocrinol (Lausanne). 2024; 14:1322326.

PMID: 38260144 PMC: 10801050. DOI: 10.3389/fendo.2023.1322326.


Systemic Dyslipidemia in Age-related Macular Degeneration: An Updated Systematic Review and Meta-analysis.

Li B, Goss D, Miller J, Lin J, Vavvas D Ophthalmol Sci. 2023; 4(1):100341.

PMID: 37869027 PMC: 10587641. DOI: 10.1016/j.xops.2023.100341.


Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining.

Moir J, Aggarwal S, Skondra D Exp Biol Med (Maywood). 2023; 248(9):798-810.

PMID: 37452694 PMC: 10468640. DOI: 10.1177/15353702231181188.